Medistim

Medistim Capital Markets Day December 16th 2024

Next steps and Innovations for Accelerated Growth

8:00 8:30 Breakfast & coffee
8:30 8:50 President & CEO Kari E. Krogstad Next steps and innovations for accelerated growth
8:50 9:00 Product & Business Mgr. Tore Skjeggestad Introducing INTUI - our new software platform – an intuitive solution optimized to provide data interpretation guidance and enhancing surgical decision-making for better patient outcomes
9:00 9:15 Prof. John D. Puskas A heart surgeon's perspective on the future of coronary revascularization in light of endovascular alternatives, CT-FFR techniques and new medication. Why does INTUI matter?
9:15 9:30 Associate Prof. Gianluca Torregrossa

A perspective on educating the next generation of surgeons - how can INTUI help? My experience as an early access user

9:30 9:40 Q&A first session
9:40 9:50 VP Medical, Anne Waaler Introduction to PATENT - a new clinical study on the use of TTFM and HFUS in Peripheral Bypass surgery for treating critical limb-threatening ischemia (CLTI) patients
9:50 10:00 Prof. Michael S. Conte (Video recording) The lead investigator of the PATENT study on its importance and value
10:00 10:15 Prof. Maarit Venermo Showcasing real-life examples and best practices on the use of TTFM and HFUS in Peripheral Bypass surgery
10:15 10:20 Q&A second session
10:20 10:30 President & CEO Kari E. Krogstad Q&A and closing remarks